Citi Pharma Ltd. (CPHL) - PKR 84.16
Ticker: CPHL • | Sector: PHARMACEUTICALS
RevRevenue
✓ GoodRs. 13.15 B
ProfitNet Profit
~ AverageRs. 892.0 M
EPSEPS
✓ Good₨3.90
ROEROE
~ Average8.2%
P/EP/E
✗ Bad21.5x
YieldDividend Yield
✓ Good4.2%
Citi Pharma Ltd. has shown positive revenue growth of 6.0% over the past year. Net income has grown by 7.1% year-over-year. The company maintains a return on equity of 8.2%.
Stock fundamentals
Key Financial Ratios
Citi Pharma Ltd. (CPHL) is listed on the Pakistan Stock Exchange (PSX) under the PHARMACEUTICALS sector. This page provides real-time CPHL share price, complete financial statements, valuation ratios, dividend history, performance charts, and stock analysis. Investors can use this data to evaluate Citi Pharma Ltd.'s growth potential, profitability, and financial health for informed investment decisions. The latest traded price is PKR 84.16. Citi Pharma Ltd. has a market capitalisation of PKR 19.80M.
At a glance
- Share Price
- PKR 84.16
- Market Cap
- PKR 19.80M
- Volume
- 1,228,265
Frequently Asked Questions
Whether CPHL is a good investment depends on your goals and risk tolerance. This page provides Citi Pharma Ltd. (CPHL) share price, financial statements, valuation ratios (P/E, P/B, ROE), dividend yield, and performance charts on the Pakistan Stock Exchange (PSX). Use this data to evaluate growth potential, profitability, and financial health before making investment decisions.